Biotech

All Articles

Cullinan, after $25M bargain, restore bispecific to Port

.Cullinan Therapeutics was made an impression on good enough with Port BioMed's bispecific immune sy...

A better look at Tough Biotech's Strong 15

.In this particular week's incident of "The Best Line," we are actually diving into Brutal Biotech's...

Lilly faces stage 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration celebrating the commendation of Al...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of notable management hirings, shootings and...

Lykos are going to inquire FDA to reconsider its decision observing denial of MDMA therapy for trauma

.Observing a poor presenting for Lykos Therapeutics' MDMA candidate for post-traumatic stress disord...

AN 2 fifty percents headcount, ceases period 3 test after data dissatisfy

.AN2 Rehabs is rethinking its own organization in reaction to poor midphase data, pledging to give u...

Merck pays for $700M for bispecific, spying autoimmune opening as well as opportunity to challenge Amgen in cancer

.Merck &amp Co. is actually paying for $700 million ahead of time to test Amgen in a blood cancer ma...

Gilead pays out J&ampJ $320M to exit licensing bargain for seladelpar

.Along With Gilead Sciences almost an FDA selection for its own liver illness drug seladelpar, the c...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may find the business setting up camping tents at basecamp behind Eli Lilly in an e...

Entero laying off personnel, vacating office and stopping R&ampD

.Bed mattress Liquidators has actually switched Entero Rehabs white colored as a sheet. The collecto...